[Relugolix/estradiol/norethisterone (uterine fibroid) - Benefit assessment according to §35a Social Code Book V]
Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen
Record ID 32018004041
German
Original Title:
Relugolix/Estradiol/Norethisteronacetat (Uterusmyome)
Details
Project Status:
Completed
URL for project:
https://www.iqwig.de/projekte/a22-01.html
Year Published:
2022
URL for published report:
https://www.iqwig.de/download/a22-01_relugolix-estradiol-norethisteronacetat_addendum-zum-auftrag-a21-112_v1-0.pdf
English language abstract:
There is no English language summary available
Publication Type:
Full HTA
Country:
Germany
MeSH Terms
- Leiomyoma
- Uterine Neoplasms
- Phenylurea Compounds
- Androgen Antagonists
- Estradiol
- Norethindrone Acetate
- Drug Therapy, Combination
Keywords
- Relugolix
- Estradiol
- Norethindrone Acetate
- Leiomyoma
- Benefit Assessment
- NCT03049735
- NCT03103087
Contact
Organisation Name:
Institute for Quality and Efficiency in Health Care (IQWiG)
Contact Address:
IQWiG, Siegburger Str. 237, 50679 Cologne, GERMANY, Tel: +49(0)221-35685, Fax: +49(0)221-356851
Contact Email:
berichte@iqwig.de
Copyright:
Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.